Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Public Health and Preventive Medicine
  4. Vol 2, Issue 3, 2022

Analysis on the efficacy and safety of treating skin eczema based on the combination of traditional Chinese and western medicine

Download as PDF

DOI: 10.23977/phpm.2022.020304 | Downloads: 14 | Views: 620

Author(s)

Kaiyan Quan 1

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Shaanxi 712000, China

Corresponding Author

Kaiyan Quan

ABSTRACT

Eczema is a common skin disease. At present, the incidence of the disease is also on the rise. Because the etiology and pathogenesis of this disease are not completely clear, there is no effective cure at present, especially the recurrence problem is a difficulty. At present, the combination of traditional Chinese and western medicine is a medical and health force alongside traditional Chinese medicine and western medicine. Methods: The clinical data of 178 cases of skin eczema treated in our hospital from January 2021 to January 2022 were retrospectively investigated and analyzed, and they were randomly divided into two groups, 89 cases in each group, and the control group was only given western medicine. Observe the syndrome differentiation treatment of TCM in group A, and analyze the therapeutic effect and safety of the two groups of patients. Results: Through clinical research, it was found that the clinical effective rate of the traditional Chinese medicine group was 88%, and that of the western medicine group was 70%. Both of them had good curative effects on eczema. However, traditional Chinese medicine or western medicine alone can't be satisfactory. In recent years, many doctors have achieved remarkable results in treating eczema by combining traditional Chinese medicine with western medicine.

KEYWORDS

Integrated traditional Chinese and western medicine treatment, skin eczema, Efficacy and safety

CITE THIS PAPER

Kaiyan Quan, Analysis on the efficacy and safety of treating skin eczema based on the combination of traditional Chinese and western medicine. MEDS Public Health and Preventive Medicine (2022) Vol. 2: 19-24. DOI: http://dx.doi.org/10.23977/phpm.2022.020304.

REFERENCES

[1] Paina M, Simons E. Two-step Egg Introduction for Prevention of Egg Allergy in High-risk Infants with Eczema (PETIT): A Randomized, Double-blind, Placebo-Controlled Trial [J]. Pediatrics, 2017, 140(Supplement 3): S193-S194.
[2] Chan S, Cornelius V, Tao C, et al. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial [J]. Current Controlled Trials in Cardiovascular Medicine, 2017, 18.
[3] Thomas C L, P Fernández-Peãns. The microbiome and atopic eczema: More than skin deep [J]. Australasian Journal of Dermatology, 2017, 58(1):18-24.
[4] Oosterhaven J, Spekhorst L S, Zhang J, et al. Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry [J]. Journal of Dermatological Treatment, 2021: 1-4.
[5] Christoffers W A, Coenraads P J. Cochrane review "Interventions for hand eczema" is published [J]. Contact Dermatitis, 2019, 81.
[6] Thomas K S, Bradshaw L E, Sach T H, et al. Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial [J]. Health technology assessment (Winchester, England), 2017, 21(16): 1-260.
[7] MD Cabana, Mckean M, Caughey A B, et al. Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial [J]. Pediatrics, 2017, 140(3): e20163000.
[8] Chan L, Deng L, Ou C, et al. Preconceptional and perinatal exposure to traffic-related air pollution and eczema in preschool children [J]. Journal of Dermatological Science, 2017, 85(2):85-95.
[9] Simpson E L, Bruin-Weller M, Flohr C, et al. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council [J]. Journal of the American Academy of Dermatology, 2017, 77(4): 623.
[10] Gerbens L, Boyce A E, Wall D, et al. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries [J]. Current Controlled Trials in Cardiovascular Medicine, 2017, 18.
[11] Kam H, Kathy T, Jeng K, et al. Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers [J]. Molecules, 2017, 22(2):291.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 1959
Visits: 87939

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.